Contact investigation in multidrug-resistant tuberculosis: ethical challenges

Area of Science:

• Public Health
• Infectious Disease Epidemiology
• Medical Ethics

Background:

• Contact investigation is crucial for controlling multidrug-resistant tuberculosis (MDR-TB) transmission.
• Disclosure of MDR-TB status to third parties for contact tracing can lead to patient stigma and discrimination.
• This stigma deters patients from revealing their status, hindering public health efforts.

Purpose of the Study:

• To explore the tension between patient confidentiality and public health interests in MDR-TB contact investigation.
• To examine how social discrimination and stigma impact patient compliance with treatment and investigation.
• To identify strategies for balancing individual rights with the need for effective public health interventions.

Main Methods:

• This study is a conceptual analysis based on existing literature and public health policy principles.
• It examines the ethical and practical challenges of MDR-TB contact investigation.
• The analysis focuses on the implications of patient disclosure and the need for contextualized solutions.

Main Results:

• Disclosure of MDR-TB status poses a significant barrier to effective contact investigation due to patient fear of stigma.
• Patient reluctance to disclose status negatively impacts treatment adherence and public health outcomes.
• Reciprocal support from TB teams is important but may not fully resolve challenges due to diverse patient contexts.

Conclusions:

• Striking a balance between patient confidentiality and public interest in MDR-TB management is complex.
• Context-specific justifications are needed to navigate disclosure dilemmas.
• Effective MDR-TB control requires addressing patient stigma and ensuring treatment adherence through tailored support.